Not only is it life or death situation when it comes down to fighting cancer, the earlier you can find out, the earlier you ...

Itovebi — also known as inavolisib — is designed to be given with drugs from Pfizer Inc. and AstraZeneca plc to treat adults ...

The title of the poster presentation for the Phase 1/2a study of [ 212 Pb]VMT01 is “First in Human Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Melanoma (MM).” “We are looking forward ...

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General ...

The Seattle oncologist spoke at Gonzaga University on Wednesday, delivering a presentation titled “How Close Are We to a ...

Seven out of 67 children who were given bluebird's (BLUE) gene therapy Skysona during clinical trials ended up developing ...

FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation ...

The approval of inavolisib is supported by findings from the phase 3 INAVO120 study evaluating the agent plus palbociclib and ...

Lesia shares her story as a breast cancer survivor: from being diagnosed in her early thirties to thriving cancer-free for ...

A daily dose of turmeric may offer health benefits for women specific to the female reproductive organs, such as PCOS. Find ...

Northwestern Medicine investigators have discovered that a novel combination therapy promotes cancer cell death and tumor ...

A borderland cancer survivor shares her story to hopefully inspire women during Breast Cancer Awareness Month.